Wuppertal, Germany

Hana Cernecka

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 16.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hana Cernecka

Introduction

Hana Cernecka is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating renal and cardiovascular diseases. With a total of 5 patents to her name, her work reflects a commitment to advancing medical science.

Latest Patents

Cernecka's latest patents include innovative prodrugs of substituted triazole derivatives. These compounds are designed for the treatment and prevention of various diseases, specifically targeting renal and cardiovascular conditions. Her inventions encompass processes for the preparation of these compounds, pharmaceutical compositions containing them, and their therapeutic applications. Another significant patent involves amide-substituted pyridinyltriazole derivatives, which also focus on the treatment and prevention of similar diseases.

Career Highlights

Throughout her career, Hana Cernecka has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer AG. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects that have the potential to improve patient outcomes.

Collaborations

Cernecka has collaborated with esteemed colleagues such as Peter Kolkhof and Thomas Neubauer. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Hana Cernecka's contributions to the field of pharmaceuticals through her innovative patents demonstrate her dedication to improving healthcare. Her work continues to pave the way for advancements in the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…